James Hardwick

Development of 6-substituted indolylquinolinones as potent Chek1 kinase inhibitors.

Michael Reilly, Laura Sepp-Lorenzino, Weikang Tao, 2006, Bioorganic & medicinal chemistry letters.

Mechanism of the switch from NO to H2O2 in endothelium-dependent vasodilation in diabetes

Yeong-Renn Chen, Yanqiao Zhang, Vahagn Ohanyan, 2021, bioRxiv.

Synthesis and evaluation of substituted benzoisoquinolinones as potent inhibitors of Chk1 kinase.

Youwei Yan, S. Stirdivant, L. Kuo, 2007, Bioorganic & medicinal chemistry letters.

Optimization of a pyrazoloquinolinone class of Chk1 kinase inhibitors.

Lawrence C Kuo, Laura Sepp-Lorenzino, Weikang Tao, 2007, Bioorganic & medicinal chemistry letters.

3-(Indol-2-yl)indazoles as Chek1 kinase inhibitors: Optimization of potency and selectivity via substitution at C6.

Lawrence C Kuo, Laura Sepp-Lorenzino, Weikang Tao, 2006, Bioorganic & medicinal chemistry letters.

Pyridyl aminothiazoles as potent Chk1 inhibitors: optimization of cellular activity.

S. Stirdivant, Weikang Tao, L. Sepp-Lorenzino, 2012, Bioorganic & medicinal chemistry letters.